Delivery Order SPE2DB22D2007-SPE2DB24FJ1EH
Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count) valued at $1,614.09, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) with a ceiling value of $1,137.74 under firm fixed-price terms. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be completed by...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 7.5 mg-46 mg capsules of the drug Qsymia, with a ceiling value of $1,504.59 and a performance period ending on May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract...
- This delivery order awards AmerisourceBergen Drug Corp $1,274.50 for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under a firm fixed-price contract. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive, non-set-aside award through the Defense Logistics Agency's Medical Supply Chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Qsymia is a combination phentermine and...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,800.01 firm-fixed-price contract is for the supply of Qsymia 3.75 mg-23 mg capsules. The award has an ultimate completion date of August 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical products and supplies to military treatment...
- This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of the prescription drug QSYMIA 7.5MG-46MG 30S. The contract, which is a firm fixed price type, has a ceiling value of $1,507.20 and runs through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.23 firm fixed price delivery order is for the supply of QSYMIA 15 MG-92 MG CAPSULE 30S, which is likely a medication used in the treatment of medical conditions. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 2, 2025, valued at $1,090.10 for the supply of Phentermine 15mg tablets (100 count) under a Defense Logistics Agency contract. The delivery order carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 29, 2025. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...